230 related articles for article (PubMed ID: 33577377)
1. Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi.
Merli F; Luminari S; Tucci A; Arcari A; Rigacci L; Hawkes E; Chiattone CS; Cavallo F; Cabras G; Alvarez I; Fabbri A; Re A; Puccini B; Barraclough A; Delamain MT; Ferrero S; Usai SV; Ferrari A; Cencini E; Pennese E; Zilioli VR; Marino D; Balzarotti M; Cox MC; Zanni M; Di Rocco A; Lleshi A; Botto B; Hohaus S; Merli M; Sartori R; Gini G; Nassi L; Musuraca G; Tani M; Bottelli C; Kovalchuk S; Re F; Flenghi L; Molinari A; Tarantini G; Chimienti E; Marcheselli L; Mammi C; Spina M
J Clin Oncol; 2021 Apr; 39(11):1214-1222. PubMed ID: 33577377
[TBL] [Abstract][Full Text] [Related]
2. Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi.
Merli F; Luminari S; Rossi G; Mammi C; Marcheselli L; Ferrari A; Spina M; Tucci A; Stelitano C; Capodanno I; Fragasso A; Baldini L; Bottelli C; Montechiarello E; Fogazzi S; Lamorgese C; Cavalli L; Federico M;
Leuk Lymphoma; 2014 Jan; 55(1):38-43. PubMed ID: 23517562
[TBL] [Abstract][Full Text] [Related]
3. The Role of Geriatric Assessment in the Management of Diffuse Large B-Cell Lymphoma.
Merli F; Pozzi S; Catellani H; Barbieri E; Luminari S
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136390
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Geriatric Assessment (CGA): A Simple Tool for Guiding the Treatment of Older Adults with Diffuse Large B-Cell Lymphoma in China.
Bai JF; Han HX; Feng R; Li JT; Wang T; Zhang CL; Liu H
Oncologist; 2020 Aug; 25(8):e1202-e1208. PubMed ID: 32436258
[TBL] [Abstract][Full Text] [Related]
5. The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi.
Cencini E; Tucci A; Puccini B; Cavallo F; Luminari S; Usai SV; Fabbri A; Pennese E; Marino D; Zilioli VR; Balzarotti M; Petrucci L; Tafuri A; Arcari A; Botto B; Zanni M; Hohaus S; Sartori R; Merli M; Gini G; Al Essa W; Musurca G; Tani M; Nassi L; Daffini R; Mammi C; Marcheselli L; Bocchia M; Spina M; Merli F
Hematol Oncol; 2023 Feb; 41(1):78-87. PubMed ID: 36177902
[TBL] [Abstract][Full Text] [Related]
6. Validation and modification of simplified Geriatric Assessment and Elderly Prognostic Index: Effective tools for older patients with diffuse large B-cell lymphoma.
Yun X; Bai J; Feng R; Li J; Wang T; Yang Y; Yin J; Qian L; Zhang S; Cao Q; Xue X; Jing H; Liu H
Cancer Med; 2023 Dec; 13(1):. PubMed ID: 38132832
[TBL] [Abstract][Full Text] [Related]
7. Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL).
Tucci A; Merli F; Fabbri A; Marcheselli L; Pagani C; Puccini B; Marino D; Zanni M; Pennese E; Flenghi L; Arcari A; Botto B; Celli M; Mammi C; Re A; Campostrini G; Tafuri A; Zilioli VR; Cencini E; Sartori R; Bottelli C; Merli M; Petrucci L; Gini G; Balzarotti M; Cavallo F; Musuraca G; Luminari S; Rossi G; Spina M
Haematologica; 2023 Apr; 108(4):1083-1091. PubMed ID: 36384247
[TBL] [Abstract][Full Text] [Related]
8. Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the
Storti S; Spina M; Pesce EA; Salvi F; Merli M; Ruffini A; Cabras G; Chiappella A; Angelucci E; Fabbri A; Liberati AM; Tani M; Musuraca G; Molinari A; Petrilli MP; Palladino C; Ciancia R; Ferrario A; Gasbarrino C; Monaco F; Fraticelli V; De Vellis A; Merli F; Luminari S
Haematologica; 2018 Aug; 103(8):1345-1350. PubMed ID: 29748444
[TBL] [Abstract][Full Text] [Related]
9. Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study.
Yhim HY; Park Y; Kim JA; Shin HJ; Do YR; Moon JH; Kim MK; Lee WS; Kim DS; Lee MW; Choi YS; Jeong SH; Kim KH; Kim J; Lee CH; Song GY; Yang DH; Kwak JY
Korean J Intern Med; 2024 May; 39(3):501-512. PubMed ID: 38287501
[TBL] [Abstract][Full Text] [Related]
10. Validation and Refinement of the Age, Comorbidities, and Albumin Index in Elderly Patients with Diffuse Large B-Cell Lymphoma: An Effective Tool for Comprehensive Geriatric Assessment.
Liu H; Zhang CL; Feng R; Li JT; Tian Y; Wang T
Oncologist; 2018 Jun; 23(6):722-729. PubMed ID: 29317552
[TBL] [Abstract][Full Text] [Related]
11. [Comprehensive geriatric assessment can predict the clinical outcomes of elderly patients with diffuse large B cell lymphoma in China].
Zhang CL; Feng R; Li JT; Tian Y; Wang T; Liu H
Zhonghua Xue Ye Xue Za Zhi; 2018 Apr; 39(4):271-276. PubMed ID: 29779319
[No Abstract] [Full Text] [Related]
12. Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi.
Merli F; Cavallo F; Salvi F; Tucci A; Musuraca G; Nassi L; Merli M; Tani M; Gini G; Ferrari A; Molinari AL; Liberati AM; Conconi A; Matteucci P; Bari A; Scalone R; Ferrero S; Zanni M; Mammi C; Luminari S
J Geriatr Oncol; 2020 Jan; 11(1):37-40. PubMed ID: 31296461
[TBL] [Abstract][Full Text] [Related]
13. Geriatric screening tools predict survival outcomes in older patients with diffuse large B cell lymphoma.
Sakurai M; Karigane D; Kasahara H; Tanigawa T; Ishida A; Murakami H; Kikuchi M; Kohashi S
Ann Hematol; 2019 Mar; 98(3):669-678. PubMed ID: 30443764
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B-cell lymphoma receiving rituximab-chemotherapy combinations.
Ong DM; Ashby M; Grigg A; Gard G; Ng ZY; Huang HE; Chong YS; Cheah CY; Devitt B; Chong G; Loh Z; Mo A; Hawkes EA
Br J Haematol; 2019 Oct; 187(1):73-81. PubMed ID: 31206608
[TBL] [Abstract][Full Text] [Related]
15. Prognostic utility of a geriatric nutritional risk index in combination with a comorbidity index in elderly patients with diffuse large B cell lymphoma.
Lee S; Fujita K; Morishita T; Negoro E; Oiwa K; Tsukasaki H; Yamamura O; Ueda T; Yamauchi T
Br J Haematol; 2021 Jan; 192(1):100-109. PubMed ID: 32410224
[TBL] [Abstract][Full Text] [Related]
16. Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial.
Vitolo U; Chiappella A; Franceschetti S; Carella AM; Baldi I; Inghirami G; Spina M; Pavone V; Ladetto M; Liberati AM; Molinari AL; Zinzani P; Salvi F; Fattori PP; Zaccaria A; Dreyling M; Botto B; Castellino A; Congiu A; Gaudiano M; Zanni M; Ciccone G; Gaidano G; Rossi G;
Lancet Oncol; 2014 Jun; 15(7):730-7. PubMed ID: 24831981
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL).
Tucci A; Martelli M; Rigacci L; Riccomagno P; Cabras MG; Salvi F; Stelitano C; Fabbri A; Storti S; Fogazzi S; Mancuso S; Brugiatelli M; Fama A; Paesano P; Puccini B; Bottelli C; Dalceggio D; Bertagna F; Rossi G; Spina M;
Leuk Lymphoma; 2015 Apr; 56(4):921-6. PubMed ID: 25110825
[TBL] [Abstract][Full Text] [Related]
18. Validation and comparison of prognostic values of GNRI, PNI, and CONUT in newly diagnosed diffuse large B cell lymphoma.
Matsukawa T; Suto K; Kanaya M; Izumiyama K; Minauchi K; Yoshida S; Oda H; Miyagishima T; Mori A; Ota S; Hashimoto D; Teshima T;
Ann Hematol; 2020 Dec; 99(12):2859-2868. PubMed ID: 32970194
[TBL] [Abstract][Full Text] [Related]
19. Impact of therapeutic management and geriatric evaluation on patient of eighty years and older with diffuse large B-cell lymphoma on survival: A systematic review.
Briand M; Gerard S; Gauthier M; Garric M; Steinmeyer Z; Balardy L
Eur J Haematol; 2022 Jan; 108(1):3-17. PubMed ID: 34496073
[TBL] [Abstract][Full Text] [Related]
20. The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma.
Cox MC; Pelliccia S; Marcheselli L; Battistini R; Arcari A; Borza PA; Patti C; Casaroli I; di Landro F; Di Napoli A; Fabbri F; Caridi M; Tafuri A; Bocci G; Musuraca G
Invest New Drugs; 2019 Jun; 37(3):548-558. PubMed ID: 31028663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
